perflubutane
Small moleculeexperimentalImaging agent
Perfluorobutane (PFB) is an inert, high-density colorless gas. It is a simple fluorocarbon with a n-butane skeleton and all the hydrogen atoms replaced with fluorine atoms. — Wikipedia
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2018 (NCT03578224)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetContrast agent
contrast agent
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPerfluorobutane ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05105087 | Early Phase 1 (Phase 1) | Jan 1, 2022 | Thomas Jefferson University |
| NCT04821284 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2021 | Thomas Jefferson University |
| NCT03578224 | Early Phase 1 (Phase 1) | Dec 31, 2018 | National Cancer Institute (NCI), Thomas Jefferson University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Thomas Jefferson University | Academic/Hospital | 3 | 3 | 2 | 2018 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1